Literature DB >> 3216946

Effects of anticonvulsants on cholinergic and GABAergic properties in the neuronal cell clone NG108-15.

C D Searles1, P A Slesinger, H S Singer.   

Abstract

The effects of anticonvulsant drugs on growth, cholinergic, and GABAergic properties were examined in the neuronal cell clone NG108-15. Cells were exposed for 4 days to valproic acid, phenobarbital, phenytoin, or carbamazepine in concentrations equivalent to therapeutic free levels in human serum. Experiments were also performed with varying concentrations of a recently proposed antiepileptic, gamma-vinyl GABA. Of these five anticonvulsants, cell growth (total protein and cell counts) was decreased with valproic acid and phenytoin but only valproic acid and gamma-vinyl GABA altered neurotransmitter markers. Therapeutic concentrations of valproic acid increased choline acetyltransferase activity to 142% of control but had no effect on either the activity of glutamate decarboxylase or the level of GABA. The effects of a higher (toxic) concentration of valproic acid (200 micrograms/ml) were similar to those induced by the differentiating agent dibutyryl cyclic AMP: both decreased cell growth, enhanced the activity of choline acetyltransferase and reduced the activity of glutamate decarboxylase. Gamma-vinyl GABA had no effect on cholinergic markers but, at 1300 micrograms/ml, increased GABA levels to 135% of control despite the reduction of glutamate decarboxylase to 68% of control. In the NG108-15 cell clone, anticonvulsants have varying effects on cell growth, differentiation, and neurotransmitter systems. Our findings do not support the proposal that the mechanism of action for valproic acid, phenobarbital, phenytoin, and carbamazepine is via alteration of GABA levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3216946     DOI: 10.1007/bf00970776

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

1.  Comparative binding studies with cholinergic ligands and histrionicotoxin at muscarinic receptors of neural cell lines.

Authors:  W Burgermeister; W L Klein; M Nirenberg; B Witkop
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

2.  Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods.

Authors:  L T Graham; M H Aprison
Journal:  Anal Biochem       Date:  1966-06       Impact factor: 3.365

3.  Sodium valproate and neural tube defects.

Authors: 
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

4.  Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.

Authors:  G Anlezark; R W Horton; B S Meldrium; C B Sawaya
Journal:  Biochem Pharmacol       Date:  1976-02-15       Impact factor: 5.858

5.  gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.

Authors:  M J Jung; B Lippert; B W Metcalf; P Böhlen; P J Schechter
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

6.  Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy.

Authors:  P J Schechter; N F Hanke; J Grove; N Huebert; A Sjoerdsma
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

7.  Effects of dipropylacetate on brain development.

Authors:  J Diaz; W D Shields
Journal:  Ann Neurol       Date:  1981-11       Impact factor: 10.422

8.  Synapse formation between clonal neuroblastoma X glioma hybrid cells and striated muscle cells.

Authors:  P Nelson; C Christian; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

9.  Two forms of rat brain glutamic acid decarboxylase differ in their dependence on free pyridoxal phosphate.

Authors:  L A Denner; J Y Wu
Journal:  J Neurochem       Date:  1985-03       Impact factor: 5.372

10.  Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.

Authors:  J W van der Laan; G Weick; G van Bleek
Journal:  Biochem Pharmacol       Date:  1985-11-01       Impact factor: 5.858

View more
  1 in total

1.  Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma.

Authors:  Soon A Park; Hye Rim Han; Stephen Ahn; Chung Heon Ryu; Sin-Soo Jeun
Journal:  Oncol Rep       Date:  2021-01-14       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.